HealthTech Pharma Research

Novartis and Uni of Oxford to join forces and use AI for diseases and drug development

Novartis and Uni of Oxford to join forces and use AI for diseases and drug development

Novartis and the University of Oxford’s Big Data Institute have announced that they are to establish a five-year research alliance using to understand complex diseases and improve drug development.

SwissCognitiveNovartis and the University of Oxford’s Big Data Institute have announced that they are to establish a five-year research alliance using to understand complex diseases and improve drug development.

The alliance plans to analyse huge data sets using and to spot disease insights that have been undetectable to scientists thus far, expecting to transform how ultra large and multiple datasets are analysed, combined and interpreted to identify early predictors of patient responses to treatments for inflammatory diseases, such as multiple sclerosis (MS) and psoriasis.

The alliance will draw on data from around 5 million patients from the UK and international partner organisations, together with anonymised data captured from relevant Novartis clinical trials.

Using the BDI’s latest statistical technology and experience in data analysis, combined with Novartis’ wealth of clinical expertise and clinical trial data, the alliance expects to predict how patients will respond to existing and new medicines.

“Our collaboration with Novartis will enable both organisations to transform the scale and efficiency of clinical research at an unprecedented rate though the sharing of data, technology, and advanced analytics expertise” said Professor Gil McVean, director of the Big Data Institute.

“The BDI enables people and projects to span traditional boundaries and scientific disciplines, and leverage technological innovation for the benefit of patients.”

Novartis and the BDI will also identify unprecedented insights into the characteristics of specific, complex diseases to understand what drives disease progression, and understand any commonalities between diseases.

read more – copyright by www.pharmatimes.com

1 Comment

  1. Venu Varma

    potential collaboration to disrupt:)

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.